| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046000057 |
| P356 | DOI | 10.1007/S00405-013-2403-6 |
| P698 | PubMed publication ID | 23463347 |
| P2093 | author name string | Wei Liu | |
| Dinghua Xie | |||
| Lihua Li | |||
| Xing Chen | |||
| Tuanfang Yin | |||
| Jihao Ren | |||
| Zian Xiao | |||
| P2860 | cites work | Immune cell profile in invasive cholesteatomas: preliminary findings | Q46185373 |
| Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells | Q46875154 | ||
| Increased amphiregulin expression as a biomarker of cholesteatoma activity. | Q54407241 | ||
| Peptide growth factors and wound healing | Q68530911 | ||
| Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma | Q74756568 | ||
| Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas | Q79787496 | ||
| Expressions of caspase-14 in human middle ear cholesteatoma | Q81388332 | ||
| Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker | Q82940477 | ||
| UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes | Q24313064 | ||
| The phosphoinositide 3-kinase pathway | Q27860738 | ||
| Cyclin D1 is a nuclear protein required for cell cycle progression in G1 | Q28269145 | ||
| NF-kappa B: ten years after | Q29618566 | ||
| Etiopathogenesis of cholesteatoma. | Q34210244 | ||
| Akt: a double-edged sword in cell proliferation and genome stability | Q34223641 | ||
| The activation of Akt/PKB signaling pathway and cell survival. | Q34405519 | ||
| Transcriptional regulation of the cyclin D1 gene at a glance | Q35985157 | ||
| The epidermal growth factor receptor family | Q36236606 | ||
| Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers | Q36493603 | ||
| Identification of Id1 in acquired middle ear cholesteatoma | Q36541407 | ||
| Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer | Q37097424 | ||
| The role of inflammatory mediators in the pathogenesis of otitis media and sequelae | Q37478120 | ||
| Acquired cholesteatoma pathogenesis: stepwise explanations | Q37692548 | ||
| Survival signaling and terminal differentiation in cholesteatoma epithelium | Q39794806 | ||
| Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue | Q39840761 | ||
| Expression of CYLD and NF-kappaB in human cholesteatoma epithelium | Q40145283 | ||
| Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma | Q42282410 | ||
| Aberrant expression of epidermal growth factor receptor in aural cholesteatoma | Q42482895 | ||
| EGFR expression in acquired middle ear cholesteatoma in children and adults | Q42492298 | ||
| Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma | Q42493536 | ||
| Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma: an analysis of protein production and gene expression | Q42520452 | ||
| Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma | Q42523556 | ||
| Epidermal growth factor in cholesteatoma--the second report: the localization in the horny layer | Q43517268 | ||
| Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma. | Q44061872 | ||
| P433 | issue | 2 | |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 265-273 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | European Archives of Oto-Rhino-Laryngology | Q2624005 |
| P1476 | title | Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium | |
| P478 | volume | 271 |
| Q37587398 | Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium |
| Q37544947 | An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. |
| Q35763374 | Differential Protein Expression in Congenital and Acquired Cholesteatomas |
| Q55410595 | Downregulation of MiR-203a Disinhibits Bmi1 and Promotes Growth and Proliferation of Keratinocytes in Cholesteatoma. |
| Q37061058 | Effects of Low-dose Triamcinolone Acetonide on Rat Retinal Progenitor Cells under Hypoxia Condition |
| Q59807420 | Follicle-stimulating hormone inhibits cervical cancer via NF-κB pathway |
| Q36954217 | MicroRNA-27a functions as a tumor suppressor in renal cell carcinoma by targeting epidermal growth factor receptor |
| Q35003647 | MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells |
| Q92702089 | Stem Cell-Induced Inflammation in Cholesteatoma is Inhibited by the TLR4 Antagonist LPS-RS |
| Q38996163 | Trop2 gene: a novel target for cervical cancer treatment |
| Q37057240 | miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6 |
Search more.